Rare diseases
Investigational molecules
Locations
Study on the Effects of Riociguat and Macitentan in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension
FranceStudy on Daratumumab, Lenalidomide, and Dexamethasone for Patients with Primary Plasma Cell Leukemia
FranceStudy on Palbociclib and Drug Combination for Patients with Hormone Receptor Positive, HER2-Positive Metastatic Breast Cancer
FranceStudy on Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma After Previous Treatment
FranceStudy of Ribociclib and Letrozole for Patients with High-Risk Estrogen Receptor-Positive, HER2-Negative Breast Cancer
FranceStudy of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation
FranceStudy on the Effect of Aflibercept Injections in Patients with Central Retinal Vein Occlusion (CRVO) and Spontaneous Retinal Arterial Pulsations (SRAPs)
FranceStudy of Ivosidenib and Azacitidine for Patients Aged 18 and Older with Untreated Acute Myeloid Leukemia with IDH1 Mutation
FranceStudy of EOS884448, Dostarlimab, and Inupadenant for Patients with Advanced Solid Tumors
FranceStudy on Bevacizumab with Temozolomide and Irinotecan for Children with Relapsed or Refractory Neuroblastoma
FranceStudy comparing dexamethasone versus immunoglobulin plus prednisone for adults with immune thrombocytopenia (ITP) who have moderate to severe bleeding
FranceStudy of Atezolizumab with High Dose Radiation vs. Radiation Alone for Patients with Oligometastatic Soft Tissue Sarcoma
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
